Response to immunotherapy in a 20-month-old boy with anti-nmda receptor encephalitis

L. C. Wong-Kisiel; T. Ji; D. L. Renaud; S. Kotagal; M. C. Patterson; J. Dalmau; K. J. MacK

doi:10.1212/WNL.0b013e3181dd41a1

Response to immunotherapy in a 20-month-old boy with anti-nmda receptor encephalitis

L. C. Wong-Kisiel, T. Ji, D. L. Renaud, S. Kotagal, M. C. Patterson, J. Dalmau, K. J. MacK

Neurology

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Original language	English (US)
Pages (from-to)	1550-1551
Number of pages	2
Journal	Neurology
Volume	74
Issue number	19
DOIs	https://doi.org/10.1212/WNL.0b013e3181dd41a1
State	Published - May 11 2010

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e3181dd41a1

Cite this

@article{4f250b630155413292c68e623da52498,

title = "Response to immunotherapy in a 20-month-old boy with anti-nmda receptor encephalitis",

author = "Wong-Kisiel, {L. C.} and T. Ji and Renaud, {D. L.} and S. Kotagal and Patterson, {M. C.} and J. Dalmau and MacK, {K. J.}",

note = "Funding Information: Disclosure: Dr. Wong-Kisiel and Dr. Ji report no disclosures. Dr. Renaud serves on the editorial board of Pediatric Neurology. Dr. Kotagal serves on the editorial board of Pediatric Neurology and has received research support from Boehringer Ingelheim. Dr. Patterson has served on scientific advisory boards for Actelion Pharmaceuticals Ltd., Shire plc, and StemCells, Inc.; has received funding for travel from Actelion Pharmaceuticals; serves as Editor for Up-To-Date and Pediatric Neurology; and receives research support from Actelion Pharmaceuticals Ltd. and from the NIH ( 1U54NS065768-01 [Co-I] ). Dr. Dalmau has received honoraria for lectures not funded by industry; receives research support from EUROIMMUN and the NIH/NCI [ RO1CA107192 (PI) and RO1CA89054-06A2 (PI) ]; has received license fee payments from EUROIMMUN for an NMDA receptor autoantibody test (patent pending PCT/US07/18092, filed: August 15, 2007); and has received royalty payments and may accrue revenue for US Patent 6,387,639, issued May 14, 2002: Patent for Ma2 autoantibody test. Dr. Mack serves as the Book Review Editor of Neurology{\textregistered} and on the editorial boards of Pediatric Neurology, the Journal of Child Neurology, and Brain and Development. ",

year = "2010",

month = may,

day = "11",

doi = "10.1212/WNL.0b013e3181dd41a1",

language = "English (US)",

volume = "74",

pages = "1550--1551",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "19",

}

TY - JOUR

T1 - Response to immunotherapy in a 20-month-old boy with anti-nmda receptor encephalitis

AU - Wong-Kisiel, L. C.

AU - Ji, T.

AU - Renaud, D. L.

AU - Kotagal, S.

AU - Patterson, M. C.

AU - Dalmau, J.

AU - MacK, K. J.

N1 - Funding Information: Disclosure: Dr. Wong-Kisiel and Dr. Ji report no disclosures. Dr. Renaud serves on the editorial board of Pediatric Neurology. Dr. Kotagal serves on the editorial board of Pediatric Neurology and has received research support from Boehringer Ingelheim. Dr. Patterson has served on scientific advisory boards for Actelion Pharmaceuticals Ltd., Shire plc, and StemCells, Inc.; has received funding for travel from Actelion Pharmaceuticals; serves as Editor for Up-To-Date and Pediatric Neurology; and receives research support from Actelion Pharmaceuticals Ltd. and from the NIH ( 1U54NS065768-01 [Co-I] ). Dr. Dalmau has received honoraria for lectures not funded by industry; receives research support from EUROIMMUN and the NIH/NCI [ RO1CA107192 (PI) and RO1CA89054-06A2 (PI) ]; has received license fee payments from EUROIMMUN for an NMDA receptor autoantibody test (patent pending PCT/US07/18092, filed: August 15, 2007); and has received royalty payments and may accrue revenue for US Patent 6,387,639, issued May 14, 2002: Patent for Ma2 autoantibody test. Dr. Mack serves as the Book Review Editor of Neurology® and on the editorial boards of Pediatric Neurology, the Journal of Child Neurology, and Brain and Development.

PY - 2010/5/11

Y1 - 2010/5/11

UR - http://www.scopus.com/inward/record.url?scp=77952137947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952137947&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181dd41a1

DO - 10.1212/WNL.0b013e3181dd41a1

M3 - Article

C2 - 20458074

AN - SCOPUS:77952137947

SN - 0028-3878

VL - 74

SP - 1550

EP - 1551

JO - Neurology

JF - Neurology

IS - 19

ER -

Response to immunotherapy in a 20-month-old boy with anti-nmda receptor encephalitis

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this